OPC Pharmaceutical Joint Stock Company - Laporan Laba Rugi (TTM)

OPC Pharmaceutical Joint Stock Company
VN ˙ HOSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi OPC Pharmaceutical Joint Stock Company menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 906,638 965,590 977,763 978,151 1,062,751 1,123,728 1,225,233 1,245,135 1,225,353 1,171,614 989,310 1,039,274 983,349 1,004,887 1,027,903 979,668 951,225 968,576 957,891 979,012
Change (%) 6.50 1.26 0.04 8.65 5.74 9.03 1.62 -1.59 -4.39 -15.56 5.05 -5.38 2.19 2.29 -4.69 -2.90 1.82 -1.10 2.20
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 535,557 572,130 572,535 557,203 603,580 643,499 709,652 751,291 716,103 637,906 524,638 523,194 500,992 526,456 524,242 512,311 504,607 522,458 525,938 528,653
Change (%) 6.83 0.07 -2.68 8.32 6.61 10.28 5.87 -4.68 -10.92 -17.76 -0.28 -4.24 5.08 -0.42 -2.28 -1.50 3.54 0.67 0.52
% of Revenue 59.07 59.25 58.56 56.96 56.79 57.26 57.92 60.34 58.44 54.45 53.03 50.34 50.95 52.39 51.00 52.29 53.05 53.94 54.91 54.00
Gross Operating Profit 371,081 393,460 405,228 420,948 459,172 480,229 515,580 493,844 509,250 533,708 464,671 516,081 482,357 478,431 503,662 467,357 446,618 446,118 431,953 450,359
Change (%) 6.03 2.99 3.88 9.08 4.59 7.36 -4.22 3.12 4.80 -12.94 11.06 -6.53 -0.81 5.27 -7.21 -4.44 -0.11 -3.18 4.26
% of Revenue 40.93 40.75 41.44 43.04 43.21 42.74 42.08 39.66 41.56 45.55 46.97 49.66 49.05 47.61 49.00 47.71 46.95 46.06 45.09 46.00
SG&A 245,698 257,049 264,080 283,233 304,777 313,516 344,855 309,918 324,616 355,073 306,463 351,220 325,179 332,311 347,256 327,523 318,112 311,684 310,586 330,516
Change (%) 4.62 2.74 7.25 7.61 2.87 10.00 -10.13 4.74 9.38 -13.69 14.60 -7.41 2.19 4.50 -5.68 -2.87 -2.02 -0.35 6.42
% of Revenue 27.10 26.62 27.01 28.96 28.68 27.90 28.15 24.89 26.49 30.31 30.98 33.79 33.07 33.07 33.78 33.43 33.44 32.18 32.42 33.76
R&D
Change (%)
% of Revenue
OpEx 781,256 829,179 836,615 840,435 908,357 957,015 1,054,507 1,061,209 1,040,719 992,978 831,102 874,413 826,170 858,767 871,498 839,834 822,719 834,142 836,524 859,169
Change (%) 6.13 0.90 0.46 8.08 5.36 10.19 0.64 -1.93 -4.59 -16.30 5.21 -5.52 3.95 1.48 -3.63 -2.04 1.39 0.29 2.71
% of Revenue 86.17 85.87 85.56 85.92 85.47 85.16 86.07 85.23 84.93 84.75 84.01 84.14 84.02 85.46 84.78 85.73 86.49 86.12 87.33 87.76
Operating Income 125,382 136,411 141,148 137,716 154,394 166,713 170,726 183,926 184,634 178,636 158,208 164,861 157,178 146,120 156,406 139,834 128,506 134,434 121,367 119,843
Change (%) 8.80 3.47 -2.43 12.11 7.98 2.41 7.73 0.38 -3.25 -11.44 4.20 -4.66 -7.04 7.04 -10.60 -8.10 4.61 -9.72 -1.26
% of Revenue 13.83 14.13 14.44 14.08 14.53 14.84 13.93 14.77 15.07 15.25 15.99 15.86 15.98 14.54 15.22 14.27 13.51 13.88 12.67 12.24
Interest Expense -6,090 -5,490 -4,945 -4,765 -4,933 -4,819 -4,161 -3,083 -1,844 -925 -487 -425 -353 -335 -223
Change (%) -9.84 -9.93 -3.64 3.52 -2.30 -13.65 -25.91 -40.17 -49.84 -47.39 -12.69 -16.94 -5.23 -33.46
% of Revenue -0.67 -0.57 -0.51 -0.49 -0.46 -0.43 -0.34 -0.25 -0.15 -0.08 -0.05 -0.04 -0.04 -0.03 -0.02
Net Income 95,661 105,791 110,426 106,662 118,401 126,377 129,630 140,378 143,368 142,128 130,952 139,143 133,340 122,234 125,128 110,240 101,110 107,060 99,133 99,014
Change (%) 10.59 4.38 -3.41 11.01 6.74 2.57 8.29 2.13 -0.87 -7.86 6.26 -4.17 -8.33 2.37 -11.90 -8.28 5.89 -7.40 -0.12
% of Revenue 10.55 10.96 11.29 10.90 11.14 11.25 10.58 11.27 11.70 12.13 13.24 13.39 13.56 12.16 12.17 11.25 10.63 11.05 10.35 10.11

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista